Winolap 5 Tablet contains Olopatadine 5 mg, an effective antihistamine used primarily for the treatment of allergic conditions. Olopatadine acts as a selective histamine H1 receptor antagonist, providing relief from symptoms associated with allergic conjunctivitis such as itching, redness, and swelling of the eyes. Additionally, it exhibits mast cell stabilizing properties, which help prevent the release of histamine and other inflammatory mediators, thereby reducing allergic responses. Winolap 5 is indicated for patients experiencing seasonal allergic rhinitis and other allergic manifestations where histamine plays a key role. The tablet formulation allows for convenient oral administration, ensuring systemic relief from allergy symptoms. It is generally well tolerated, with a low incidence of adverse effects; however, some patients may experience mild side effects such as headache, dry mouth, or dizziness. Caution is advised in individuals with known hypersensitivity to Olopatadine or any of the tablet’s excipients. Dosage should be individualized based on the severity of symptoms and patient response, and it is recommended to follow the prescribing physician’s instructions closely. Winolap 5 Tablet offers a reliable therapeutic option for managing allergic conditions, improving patient comfort and quality of life.